Pharmacokinetics and Safety of Single-Dose Sotrovimab in High-Risk Children and Adolescents With Mild-to-Moderate COVID-19.

Moore J, Austin D, Aylott A, Daniluk J, Gaffney LA, Hezareh M, Nader A, Noormohamed N, Parado C, Peppercorn A, Sachdeva Y, Segal S, Steplewski K, Yates PJ, Walker J, Skingsley A

Open source

DOI: 10.1093/jpids/piaf027
Published: 2025 May 13
Container: Journal of the Pediatric Infectious Diseases Society
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jpids/piaf027,
  title = {Pharmacokinetics and Safety of Single-Dose Sotrovimab in High-Risk Children and Adolescents With Mild-to-Moderate COVID-19.},
  author = {Moore J and Austin D and Aylott A and Daniluk J and Gaffney LA and Hezareh M and Nader A and Noormohamed N and Parado C and Peppercorn A and Sachdeva Y and Segal S and Steplewski K and Yates PJ and Walker J and Skingsley A},
  year = {2025},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  doi = {10.1093/jpids/piaf027},
  url = {https://doi.org/10.1093/jpids/piaf027}
}

RIS

TY  - JOUR
TI  - Pharmacokinetics and Safety of Single-Dose Sotrovimab in High-Risk Children and Adolescents With Mild-to-Moderate COVID-19.
AU  - Moore J
AU  - Austin D
AU  - Aylott A
AU  - Daniluk J
AU  - Gaffney LA
AU  - Hezareh M
AU  - Nader A
AU  - Noormohamed N
AU  - Parado C
AU  - Peppercorn A
AU  - Sachdeva Y
AU  - Segal S
AU  - Steplewski K
AU  - Yates PJ
AU  - Walker J
AU  - Skingsley A
PY  - 2025
JO  - Journal of the Pediatric Infectious Diseases Society
DO  - 10.1093/jpids/piaf027
UR  - https://doi.org/10.1093/jpids/piaf027
ER  -

APA

J, M., D, A., A, A., J, D., LA, G., M, H., A, N., N, N., C, P., A, P., Y, S., S, S., K, S., PJ, Y., J, W., & A, S. (2025). Pharmacokinetics and Safety of Single-Dose Sotrovimab in High-Risk Children and Adolescents With Mild-to-Moderate COVID-19.. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piaf027

Source records

pubmed · retrieved 2026-09-27T16:46:00.766Z
europe-pmc · retrieved 2026-09-27T16:46:00.783Z